AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Cellebrite DI Ltd.
Video analysis: CLBT
All videosNo video analysis for this stock yet. Request one from our team.
News: CLBT
Chris Wade, director de tecnología de Cellebrite, liderará Cellebrite Labs
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), un líder mundial en soluciones digitales de investigación e inteligencia impulsadas por IA, anunció hoy la
Cellebrite CTO Chris Wade to Lead Cellebrite Labs, Sharpening Focus on Mobile Research
Strategic move strengthens Cellebrite's flagship access, extraction and decoding technology as Cellebrite Labs joins Wade's Innovation Hub TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
Cellebrite Initiates Plans to Redomicile in the United States
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors Who Suffered Losses to Contact the Firm About the Securities Investigation
New York, New York--(Newsfile Corp. - September 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Kaplan Fox Urges Cellebrite DI Ltd. (CLBT) Investors to Contact the Firm About Possible Securities Law Violations
New York, New York--(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Cellebrite DI (NASDAQ:CLBT) and Riskified (NYSE:RSKD) Head to Head Contrast
Riskified (NYSE: RSKD - Get Free Report) and Cellebrite DI (NASDAQ: CLBT - Get Free Report) are both technology companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Earnings and Valuation This table compares Riskified and Cellebrite
Kaplan Fox Encourages Investors of Cellebrite DI Ltd. (CLBT) to Contact the Firm to Learn About Their Legal Rights
New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Cellebrite Announces Upcoming Investor Events in September
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
